Discussion about this post

User's avatar
I, Bayes's avatar

Excellent points on buybacks. They are just a tool, not a universal shareholder value booster. Even if management doesn’t use them to game EPS, they often overestimate the company’s intrinsic value and buy when the stock is expensive.

On the other hand, some buybacks might be quite healthy. For example, PayPal’s valuation seems low enough. Alphabet’s program is huge in absolute terms, but in a way it’s just the other side of their massive capex: they need AI → hire expensive staff with SBC → compensate dilution.

Expand full comment

No posts